Target
Ubiquitin-conjugating enzyme E2 E1
Ligand
BDBM329915
Substrate
n/a
Meas. Tech.
HTRF Assay
IC50
<10±n/a nM
Citation
 Afroze, RBharathan, ITCiavarri, JPFleming, PEGaulin, JLGirard, MLangston, SPSoucy, FWong, TYe, Y Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme US Patent  US9663525 Publication Date 5/30/2017 
Target
Name:
Ubiquitin-conjugating enzyme E2 E1
Synonyms:
E2 ubiquitin-conjugating enzyme E1 | UB2E1_HUMAN | UBCH6 | UBE2E1
Type:
n/a
Mol. Mass.:
21408.98
Organism:
Homo sapiens (Human)
Description:
P51965
Residue:
193
Sequence:
MSDDDSRASTSSSSSSSSNQQTEKETNTPKKKESKVSMSKNSKLLSTSAKRIQKELADITLDPPPNCSAGPKGDNIYEWRSTILGPPGSVYEGGVFFLDITFTPEYPFKPPKVTFRTRIYHCNINSQGVICLDILKDNWSPALTISKVLLSICSLLTDCNPADPLVGSIATQYMTNRAEHDRMARQWTKRYAT
  
Inhibitor
Name:
BDBM329915
Synonyms:
(rac)-{(1R,2R,3S,4R)-4-[(2-{3-[2-chloro-1-(hydroxymethyl)-1- | US10202389, Compound I-123 | US9663525, Compound I-123 | US9796725, Compound I-123
Type:
Small organic molecule
Emp. Form.:
C22H28ClN5O6S
Mol. Mass.:
526.006
SMILES:
CC(CO)(CCl)c1cccc(c1)-c1cc2nccc(N[C@@H]3C[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]3O)n2n1 |r|
Structure:
Search PDB for entries with ligand similarity: